Richard A. Meier - 02 May 2022 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
Director
Signature
/s/ Eric Fleekop, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
02 May 2022
Net transactions value
+$64.53
Form type
4
Filing time
04 May 2022, 12:21:04 UTC
Previous filing
04 Feb 2022
Next filing
16 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Options Exercise $318,410 +8,500 +8.6% $37.46 107,892 02 May 2022 Direct
transaction BMRN Common Stock Sale $316,867 -3,860 -3.6% $82.09 104,032 02 May 2022 Direct
transaction BMRN Common Stock Sale $1,478 -18 -0.02% $82.12 104,014 02 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to buy Common Stock) Options Exercise $0 -8,500 -100% $0.000000* 0 02 May 2022 Common Stock 8,500 $37.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the number of options outstanding after the transactions from this specific stock option grant.